{
    "clinical_study": {
        "@rank": "166668", 
        "arm_group": [
            {
                "arm_group_label": "Online self-help + varenicline", 
                "arm_group_type": "Active Comparator", 
                "description": "Participants in this control arm will receive standard self-help education materials delivered via an Internet-based program (accessible via smart phone) and a standard course of varenicline."
            }, 
            {
                "arm_group_label": "Augmented online self-help + varenicline", 
                "arm_group_type": "Experimental", 
                "description": "Participants will receive standard self-help educational materials available online or via smart phone plus additional assistance managing medication side-effects and nicotine withdrawal symptoms (ie, MyMAP or My Mobile Advice Program), plus a standard course of varenicline."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this pilot study is to evaluate the acceptability and feasibility of the\n      proposed smoking cessation intervention (called MyMAP or My Mobile Advice Program)."
        }, 
        "brief_title": "Internet-based Medication Adherence Program for Nicotine Dependence Treatment", 
        "completion_date": {
            "#text": "September 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Smoking Cessation", 
            "Medication Adherence"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Tobacco Use Disorder", 
                "Smoking"
            ]
        }, 
        "detailed_description": {
            "textblock": "Investigators will develop and pilot test a prototype of the MyMAP intervention.The\n      intervention is designed to help smokers better manage issues known to reduce treatment\n      adherence (withdrawal symptoms, medication side-effects, low motivation, and inadequate\n      behavioral skills for medication adherence) and to facilitate greater communication between\n      patients and providers so clinicians can provide appropriate oversight of medication use,\n      intervene when medically necessary, and address patient concerns that may otherwise lead to\n      non-adherence or early treatment termination."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  An invited member of Group Health, a health care system in the Pacific Northwest\n\n          -  Plan to remain enrolled in Group Health for the next 6 months\n\n          -  aged 18 - 65\n\n          -  Eligible for smoking cessation treatment through Group Health insurance coverage\n\n          -  smoke >= 10 cigs a day\n\n          -  speak and read in English\n\n          -  willing to use varenicline and no contraindications for this medication\n\n          -  ready to quit smoking\n\n          -  have a smart phone with internet access\n\n          -  willing to receive study texts and emails\n\n          -  receive care at a Group Health clinic and have electronic medical records in this\n             system\n\n          -  fill prescriptions through the Group Health pharmacy\n\n        Exclusion Criteria:\n\n          -  lifetime history of dementia\n\n          -  psychosis or bipolar disorder based on self-report or medical record review\n\n          -  hearing, comprehension or visual limitations that preclude full study participation\n\n          -  current use of other forms of tobacco\n\n          -  any medical contraindication for varenicline use\n\n          -  documented history of suicidal ideation/intent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 9, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02136498", 
            "org_study_id": "1R34DA034612"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Online self-help + varenicline", 
                    "Augmented online self-help + varenicline"
                ], 
                "description": "Standard 12 week course of varenicline", 
                "intervention_name": "Varenicline", 
                "intervention_type": "Drug", 
                "other_name": "Chantix"
            }, 
            {
                "arm_group_label": [
                    "Online self-help + varenicline", 
                    "Augmented online self-help + varenicline"
                ], 
                "description": "Standard self-help education for smoking cessation, delivered via the Internet and accessible via smart phone or other internet-capable device.", 
                "intervention_name": "Self-help education", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Augmented online self-help + varenicline", 
                "description": "Standard self-help intervention for smoking cessation accessed via smart phone or other internet-capable device + personalized feedback and advice for managing nicotine withdrawal symptoms and medication side-effects + motivational encouragement (ie, the MyMAP program).", 
                "intervention_name": "MyMAP (My Mobile Advice Program)", 
                "intervention_type": "Behavioral"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Nicotine", 
                "Nicotine polacrilex", 
                "Varenicline"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "smoking cessation", 
            "varenicline", 
            "adherence"
        ], 
        "lastchanged_date": "May 28, 2014", 
        "location": {
            "contact": {
                "email": "SaintJohnson.J@ghc.org", 
                "last_name": "Saint-Johnson"
            }, 
            "facility": {
                "address": {
                    "city": "Seattle", 
                    "country": "United States", 
                    "state": "Washington", 
                    "zip": "98101"
                }, 
                "name": "Group Health Research Institute"
            }, 
            "investigator": {
                "last_name": "Kathy Bradley, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Internet-based Medication Adherence Program for Nicotine Dependence Treatment", 
        "other_outcome": [
            {
                "description": "Satisfaction with the prototype intervention", 
                "measure": "Participant satisfaction", 
                "safety_issue": "No", 
                "time_frame": "5 mo follow-up"
            }, 
            {
                "description": "Satisfaction with the prototype intervention", 
                "measure": "Participant satisfaction", 
                "safety_issue": "No", 
                "time_frame": "12 week follow-up"
            }
        ], 
        "overall_contact": {
            "email": "saintjohnson.j@ghc.org", 
            "last_name": "Jackie Saint-Johnson"
        }, 
        "overall_official": [
            {
                "affiliation": "Group Health Research Institute", 
                "last_name": "Jennifer McClure, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of California, Davis", 
                "last_name": "Sheryl Catz, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Michigan", 
                "last_name": "Larry An, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Federal Government", 
                "United States: Institutional Review Board", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Self-report of no-smoking, even a puff during the last 7 days.", 
            "measure": "Point prevalence abstinence", 
            "safety_issue": "No", 
            "time_frame": "5 month follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02136498"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Number of days varenicline was used", 
                "measure": "Number of days of varenicline use", 
                "safety_issue": "No", 
                "time_frame": "12 week follow-up"
            }, 
            {
                "description": "Number of days varenicline was used", 
                "measure": "Number of days of varenicline use", 
                "safety_issue": "No", 
                "time_frame": "5 mo follow-up"
            }
        ], 
        "source": "Group Health Cooperative", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "University of Michigan", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of California, Davis", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Group Health Cooperative", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}